Chengdu
Disclosure information not submitted.
2962 - A Phase II Clinical Trial of Sintilimab Combined with Lower Dose Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Tuesday, October 1, 202412:45 PM – 2:00 PM ET
